Outrageous prices of orphan drugs: a call for collaboration-Reference-Cited by-同舟云学术

Outrageous prices of orphan drugs: a call for collaboration

Published:2018-09 Issue:10149 Volume:392 Page:791-794
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Luzzatto Lucio,Hyry Hanna I,Schieppati Arrigo,Costa Enrico,Simoens Steven,Schaefer Franz,Roos Jonathan C P,Merlini Giampaolo,Kääriäinen Helena,Garattini Silvio,Hollak Carla E,Remuzzi Giuseppe,Barbui Tiziano,Benigni Ariela,Costa Enrico,Daina Erica,Garattini Silvio,Gramaglia Donatella,Hollak Carla E M,Hyry Hanna,Kaarinen Helena,Licht Christoph,Luzzatto Lucio,Merlini Giampaolo,Notaro Rosario,Remuzzi Giuseppe,Schaefer Franz,Schieppati Arrigo,Simoens Steven

Publisher

Elsevier BV

Subject

General Medicine

Reference18 articles.

1. Negotiating prices of drugs for rare diseases;Henrard;Bull World Health Organ,2016

2. Paying for the orphan drug system: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments?;Hughes-Wilson;Orphanet J Rare Dis,2012

3. Rare diseases and effective treatments: are we delivering?;Luzzatto;Lancet,2015

4. Rare cancers: a sea of opportunity;Boyd;Lancet Oncol,2016

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Benefit and Revenues of Drugs Affected by Rare Pediatric Disease Priority Review Vouchers, 2017-2023;The Journal of Pediatrics;2024-12

2. Successes and pitfalls in orphan drug development for sickle cell disease;Blood Advances;2024-05-20

3. Safety Profile of Monoclonal Antibodies and Subsequent Drug Developments in the Treatment of Paroxysmal Nocturnal Hemoglobinuria;Medicina;2024-02-24

4. The inhibition of several components of terminal complement pathway results in C3 binding to PNH red blood cells;American Journal of Hematology;2024-01-24

5. Together for the greater goods: legitimising social innovation in the pharmaceutical field;Innovation: The European Journal of Social Science Research;2024-01-02